Growth and Expansion of Regenerative Medicine Market

Paradigm Shifts in Pharma R&D Models Accelerate the Growth of Innovative Technology Segments in Regenerative Medicine
Share this:
Published: 30 Jun 2016

The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments such as oncology and cardiovascular disorders, moving away from traditional segments such as dermatology and musculoskeletal disorders. On the technology front, gene therapy is becoming lucrative with the entry of cell-gene combination therapies and mRNA therapeutics that are touted as major milestones in biotechnology.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..